BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Karachaliou N, Bracht JWP, Fernandez Bruno M, Drozdowskyj A, Gimenez Capitan A, Moran T, Carcereny E, Cobo M, Domine M, Chaib I, Ramirez JL, Camps C, Provencio M, Vergnenegre A, Lopez-Vivanco G, Majem M, Massuti B, Rosell R. Association of PALB2 Messenger RNA Expression with Platinum-Docetaxel Efficacy in Advanced Non-Small Cell Lung Cancer. J Thorac Oncol 2019;14:304-10. [PMID: 30472259 DOI: 10.1016/j.jtho.2018.10.168] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Padella A, Fontana MC, Marconi G, Fonzi E, Petracci E, Ferrari A, Baldazzi C, Papayannidis C, Ghelli Luserna Di Rorá A, Testoni N, Castellani G, Haferlach T, Martinelli G, Simonetti G. Loss of PALB2 predicts poor prognosis in acute myeloid leukemia and suggests novel therapeutic strategies targeting the DNA repair pathway. Blood Cancer J 2021;11:7. [PMID: 33414401 DOI: 10.1038/s41408-020-00396-x] [Reference Citation Analysis]
2 Santarpia M, Aguilar A, Chaib I, Cardona AF, Fancelli S, Laguia F, Bracht JWP, Cao P, Molina-Vila MA, Karachaliou N, Rosell R. Non-Small-Cell Lung Cancer Signaling Pathways, Metabolism, and PD-1/PD-L1 Antibodies. Cancers (Basel) 2020;12:E1475. [PMID: 32516941 DOI: 10.3390/cancers12061475] [Cited by in Crossref: 10] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
3 Karachaliou N, Arrieta O, Giménez-Capitán A, Aldeguer E, Drozdowskyj A, Chaib I, Reguart N, Garcia-Campelo R, Chen JH, Molina-Vila MA, Rosell R; Spanish Lung Cancer Group (SLCG). BRCA1 Expression and Outcome in Patients With EGFR-Mutant NSCLC Treated With Gefitinib Alone or in Combination With Olaparib. JTO Clin Res Rep 2021;2:100113. [PMID: 34589994 DOI: 10.1016/j.jtocrr.2020.100113] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Pan W, Lu K, Wang W, Yao J, Hou Y. PALB2 as a potential prognostic biomarker for colorectal cancer. Comput Biol Chem 2020;87:107289. [PMID: 32497983 DOI: 10.1016/j.compbiolchem.2020.107289] [Reference Citation Analysis]
5 Abdel-Ghany S, Raslan S, Tombuloglu H, Shamseddin A, Cevik E, Said OA, Madyan EF, Senel M, Bozkurt A, Rehman S, Sabit H. Vorinostat-loaded titanium oxide nanoparticles (anatase) induce G2/M cell cycle arrest in breast cancer cells via PALB2 upregulation. 3 Biotech 2020;10:407. [PMID: 32904337 DOI: 10.1007/s13205-020-02391-2] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 3.5] [Reference Citation Analysis]
6 Zong Y, Li Q, Zhang F, Xian X, Wang S, Xia J, Li J, Tuo Z, Xiao G, Liu L, Li G, Zhang S, Wu G, Liu J. SDH5 Depletion Enhances Radiosensitivity by Regulating p53: A New Method for Noninvasive Prediction of Radiotherapy Response. Theranostics 2019;9:6380-95. [PMID: 31588224 DOI: 10.7150/thno.34443] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]